Dual Versus Triple Therapy for Atrial Fibrillation After Percutaneous Coronary Intervention: A Systematic Review and Meta-analysis

BACKGROUND: The safety and effectiveness of dual therapy (direct oral anticoagulant [DOAC] plus P2Y12 inhibitor) versus triple therapy (vitamin K antagonist plus aspirin and P2Y12 inhibitor) in patients with nonvalvular atrial fibrillation (AF) after percutaneous coronary intervention (PCI) is uncle...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Ann Intern Med
Autori principali: Khan, Safi U., Osman, Mohammed, Khan, Muhammad U., Khan, Muhammad Shahzeb, Zhao, Di, Mamas, Mamas A., Savji, Nazir, Al-Abdouh, Ahmad, Hasan, Rani K., Michos, Erin D.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2020
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7489449/
https://ncbi.nlm.nih.gov/pubmed/32176890
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7326/M19-3763
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi